STOCK TITAN
  1. Home
  2. News
  3. BFRGW

Bullfrog AI Holdings, Inc. Warrants - BFRGW STOCK NEWS

Welcome to our dedicated page for Bullfrog AI Holdings Warrants news (Ticker: BFRGW), a resource for investors and traders seeking the latest updates and insights on Bullfrog AI Holdings Warrants stock.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

News

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

Rhea-AI Summary

BullFrog AI and the Lieber Institute for Brain Development (LIBD) announced significant progress in their collaboration to identify novel drug targets for neuropsychiatric disorders. Using AI and machine learning, they have discovered patient subgroups within conditions like major depression, schizophrenia, and bipolar disorder. This approach led to identifying key genes that present new potential drug targets. BullFrog AI is applying Causal AI to validate these targets, aiming to develop targeted treatments for psychiatric disorders. The collaboration has also started engagements with pharmaceutical companies for strategic partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.92%
Tags
AI
-
News

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

Rhea-AI Summary
BullFrog AI Holdings, Inc. announces Chief Scientific Officer's presentation on Quantum Assisted AI/ML for Precision Medicine at Bio-IT World Conference & Expo. The presentation focuses on using quantum methods to analyze disease patterns, including multi-omics cancer data and severe COVID-19 patient classification, showcasing the potential of quantum computing in revolutionizing precision medicine.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
conferences AI
-
News

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the availability of a fireside chat recording featuring CEO Vin Singh and Dr. Daniel Weinberger. The collaboration with Lieber Institute for Brain Development explores psychiatric conditions using advanced graph analytics on 2,800 brain samples, revealing potential biological subtypes within disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.49%
Tags
AI
News

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

Rhea-AI Summary
BullFrog AI Holdings, Inc. appoints Dr. Thomas W. Chittenden as Chief Scientific Officer, bringing extensive experience in AI, machine learning, and drug discovery. Dr. Chittenden's leadership is expected to drive innovation in drug development and accelerate BullFrog AI's mission.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.69%
Tags
management AI
-
News

BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the Underwriter's decision to exercise their over-allotment option to purchase 218,382 shares of the Company's common stock. The offering was made via a prospectus filed with the SEC and facilitated by WallachBeth Capital, LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
AI
-
News

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

Rhea-AI Summary
BullFrog AI Holdings, Inc. announces a fireside chat with CEO Vin Singh and Dr. Daniel R. Weinberger to discuss groundbreaking collaboration with LIBD on psychiatric research using AI and machine learning. The partnership aims to provide new insights into brain disorders and potential treatments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.15%
Tags
AI
News

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

Rhea-AI Summary
WallachBeth Capital LLC announced that BullFrog AI Holdings, Inc. has completed an underwritten public offering, raising approximately $5.7 million. The company offered 1,507,139 shares of common stock at a public offering price of $3.782 per share. Additionally, the underwriters have a 45-day option to purchase an additional 226,071 shares to cover over-allotments. The offering was managed by WallachBeth Capital, LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
offering AI
-
News

BullFrog AI Announces Closing of $5.7 Million Public Offering

Rhea-AI Summary
BullFrog AI Holdings, Inc. (NASDAQ:BFRG) has closed an underwritten public offering, raising approximately $5,700,000 in gross proceeds. The company intends to use the net proceeds for working capital and general corporate purposes. WallachBeth Capital, LLC acted as the sole book-running manager for the offering. The offering was made in accordance with a registration statement on Form S-1 (File No. 333-276740) filed with the SEC and became effective on January 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
offering AI
-
News

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

Rhea-AI Summary
WallachBeth Capital LLC announced that BullFrog AI Holdings, Inc. priced an underwritten public offering of 1,507,139 shares of common stock and accompanying warrants, with gross proceeds of approximately $5,700,000. The offering is expected to close on February 5, 2024, subject to customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.34%
Tags
offering AI
News

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

Rhea-AI Summary
BullFrog AI Holdings, Inc. announced the pricing of an underwritten public offering of an aggregate of 1,507,139 shares of common stock and accompanying warrants to purchase 1,507,139 shares of common stock at a public offering price of $3.782 per share, resulting in gross proceeds of approximately $5,700,000. The company also granted the underwriters a 45-day option to purchase an additional 226,071 shares of common stock and/or warrants to cover over-allotments. The net proceeds from the offering will be used for working capital and other general corporate purposes. The offering is expected to close on February 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.34%
Tags
offering AI

FAQ

What is the current stock price of Bullfrog AI Holdings Warrants (BFRGW)?

The current stock price of Bullfrog AI Holdings Warrants (BFRGW) is $0.179 as of November 1, 2024.

What is Bullfrog AI Holdings Inc?

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company utilizing machine learning to advance medicine and enhance human health.

What technology does Bullfrog AI use?

Bullfrog AI uses artificial intelligence and machine learning to advance medicines for both internal and external projects.

What is bfLEAP?

bfLEAP is Bullfrog AI's platform technology, an analytical AI/ML platform that overcomes scalability and flexibility challenges faced by researchers and clinicians.

What is the focus of Bullfrog AI's work?

Bullfrog AI focuses on creating a more precise, multi-dimensional understanding of data to advance medicine and healthcare.

How can I learn more about Bullfrog AI?

For more information, visit Bullfrog AI on their website: https://bullfrogai.com or on LinkedIn: https://www.linkedin.com/company/bullfrogai/

Stock BFRGW logo
Bullfrog AI Holdings, Inc. Warrants

Nasdaq:BFRGW

BFRGW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

BFRGW Stock Data

7.85M
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Pharmaceutical Preparations
United States of America
GAITHERSBURG